光子计数CT肝脏脂肪定量与PDFF对照验证
前瞻性纳入444例受试者,以质子密度脂肪分数(PDFF)为参考,评估光子计数CT脂肪分数(CTFF)在志愿者、MASLD及异质性肝病队列中的一致性。结果显示CTFF与PDFF一致性极佳,所有亚组ICC均为0.98,最大偏倚0.80%。诊断肝脏脂肪变性及其分级的AUC-ROC和AUC-PR均超过0.99。
要点
- CTFF与PDFF在不同管电压和剂量条件下一致性均极佳,可用于临床脂肪定量。
- CTFF对脂肪变性检出和分级的AUC均超0.99,诊断效能很高。
- 在MASLD和异质性肝病队列中CTFF诊断准确性同样得到验证。
核心结论
- CTFF与PDFF一致性极佳,在不同扫描参数和肝脏疾病条件下诊断性能稳定。
- CTFF对肝脏脂肪变性的检出和分级均具有很高的诊断准确性,所有AUC-ROC和AUC-PR均超过0.99。
研究设计与样本
- 前瞻性研究,总体纳入444例受试者,平均年龄44.9±14.3岁,男性264例。
- 志愿者队列297例,随机分配至120-kVp或140-kVp组,并进一步分为高剂量和低剂量亚组。
- 临床验证队列包括MASLD 86例和异质性肝病61例,PCCT与PDFF检查间隔不超过1个月。
- 以PDFF作为脂肪变性分级的参考标准,统计方法包括ICC、Bland-Altman分析、Mann-Whitney U检验、Kruskal-Wallis检验、AUC-ROC和AUC-PR。
关键影像表现/征象
- CTFF与PDFF在所有志愿者亚组中ICC均为0.98,R²≥0.96,最大偏倚为0.80%(95%CI:0.70-0.89%)。
- 各亚组间PDFF与CTFF绝对误差无显著差异(所有p>0.05)。
诊断标准与关键数值
- CTFF对脂肪变性检出和分级的所有AUC-ROC和AUC-PR均超过0.99。
- CTFF与PDFF最大偏倚为0.80%(95%CI:0.70-0.89%),所有亚组ICC均为0.98,R²≥0.96。
临床应用与阅片要点
- CTFF可在120-kVp或140-kVp及不同剂量条件下稳定用于肝脏脂肪定量,便于日常扫描方案灵活应用。
- 对怀疑脂肪肝而难以行MRI-PDFF的患者,CTFF可作为高准确性替代定量手段。
- 在存在MASLD或其他异质性肝病的患者中,CTFF仍保持很高的诊断准确性。
局限性
- 志愿者队列的CTFF技术验证与临床队列的疾病条件不同,原文未报告跨队列直接比较的偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the robustness and grading performance of Photon-counting CT (PCCT)-derived fat fraction (CTFF) in liver fat quantification across different protocols and cohorts with varying liver conditions, using proton density fat fraction (PDFF) as the reference.
MATERIALS AND METHODS: The prospective study enrolled 297 participants in the Volunteer cohort. Participants were randomly assigned to 120-kVp or 140-kVp groups and subdivided into high- and low-dose subgroups for technical validation. Clinical validation was performed in two cohorts: participants with metabolic dysfunction-associated steatotic liver disease (MASLD, n = 86) and heterogeneous liver diseases (HLD, n = 61). PCCT and PDFF (reference standard for grading) were performed within 1 month. Statistical analyses included intraclass correlation coefficients, Bland-Altman analysis, Mann-Whitney U and Kruskal-Wallis tests, and areas under the receiver operating characteristic (AUC-ROC) and precision-recall curves (AUC-PR).
RESULTS: Overall, 444 participants were included (age 44.9 ± 14.3 years; 264 men). In the Volunteer cohort, CTFF showed excellent agreement with PDFF (all ICCs = 0.98; R2 ≥0.96) with a maximum bias of 0.80% (95% CI: 0.70-0.89%), across the whole-cohort and subgroups. No significant differences in the absolute error between PDFF and CTFF were observed across all subgroups (all p > 0.05). CTFF achieved high diagnostic accuracy for both the detection and grading of steatosis with all AUC-ROC and AUC-PR exceeding 0.99. The diagnostic accuracy of CTFF was verified in the MASLD and HLD cohorts.
CONCLUSION: CTFF demonstrated excellent agreement with PDFF and consistent diagnostic performance across diverse scan settings and liver conditions.
引用
- Xu, Yuan, Cai, et al. Robust Liver Steatosis Quantification Using Photon-Counting CT in Comparison to PDFF: Validation across Protocols and Cohorts. Acad Radiol. 2026. PMID: 42705927. doi:10.1016/j.acra.2026.08.094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。